GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ELAN · Jun 30, 2021

Elanco Animal Health Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001739104-21-000013General Corporate
Debt relative to revenue82thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.debt_to_revenue

476.70% · OPTIONAL · VALID

Capex intensity0thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

1.33% · OPTIONAL · VALID

Operating cash generation80thOwn-history percentile · N=10
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

11.65% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

118.15% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure27thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

113.37% · OPTIONAL · VALID

Gross margin100thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.gross_margin

56.92% · CORE · VALID

R&D intensity9thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

7.35% · OPTIONAL · VALID

SBC intensity30thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.25% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History28 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
496.05%
Current
476.70%
Delta
-19.35%
Capex Intensity Decreased
Previous
1.45%
Current
1.33%
Delta
-0.12%
Cash Generation Increased
Previous
1.77%
Current
11.65%
Delta
9.88%
Growth Increased
Previous
88.84%
Current
118.15%
Delta
29.31%
Inventory Pressure Decreased
Previous
114.65%
Current
113.37%
Delta
-1.28%
Margin Increased
Previous
54.19%
Current
56.92%
Delta
2.73%
R And D Intensity Increased
Previous
7.17%
Current
7.35%
Delta
0.18%
Sbc Intensity Increased
Previous
1.21%
Current
1.25%
Delta
0.04%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · ELAN Fundamental State →Has State · Elanco Animal Health Inc →Transitioned To · ELAN Fundamental State →Transitioned To · ELAN BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · ELAN CAPEX_INTENSITY_DECREASED →Transitioned To · ELAN CASH_GENERATION_INCREASED →Transitioned To · ELAN GROWTH_INCREASED →Transitioned To · ELAN INVENTORY_PRESSURE_DECREASED →Transitioned To · ELAN MARGIN_INCREASED →Transitioned To · ELAN R_AND_D_INTENSITY_INCREASED →Transitioned To · ELAN SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.